Dyadic International (NASDAQ:DYAI) Stock Price Passes Above 50 Day Moving Average – Time to Sell?

Dyadic International, Inc. (NASDAQ:DYAI)’s stock price passed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $1.56 and traded as high as $1.99. Dyadic International shares last traded at $1.73, with a volume of 171,662 shares changing hands.

Wall Street Analyst Weigh In

Separately, HC Wainwright reaffirmed a “buy” rating and issued a $6.00 price objective on shares of Dyadic International in a report on Thursday, November 14th.

Dyadic International Price Performance

The company has a debt-to-equity ratio of 1.54, a current ratio of 5.15 and a quick ratio of 5.15. The company has a 50-day simple moving average of $1.56 and a 200-day simple moving average of $1.39. The stock has a market cap of $51.04 million, a PE ratio of -7.50 and a beta of 0.89.

Dyadic International (NASDAQ:DYAI) last released its quarterly earnings results on Tuesday, November 12th. The biotechnology company reported ($0.01) EPS for the quarter, beating the consensus estimate of ($0.07) by $0.06. Dyadic International had a negative net margin of 188.09% and a negative return on equity of 149.16%. The business had revenue of $1.96 million for the quarter, compared to analyst estimates of $1.05 million. During the same period in the prior year, the business earned ($0.06) earnings per share. Sell-side analysts anticipate that Dyadic International, Inc. will post -0.18 EPS for the current fiscal year.

Hedge Funds Weigh In On Dyadic International

An institutional investor recently raised its position in Dyadic International stock. Chapin Davis Inc. boosted its holdings in Dyadic International, Inc. (NASDAQ:DYAI) by 2.5% during the 3rd quarter, according to its most recent disclosure with the SEC. The firm owned 868,301 shares of the biotechnology company’s stock after buying an additional 21,000 shares during the period. Chapin Davis Inc. owned approximately 2.97% of Dyadic International worth $903,000 at the end of the most recent reporting period. 27.95% of the stock is currently owned by hedge funds and other institutional investors.

Dyadic International Company Profile

Dyadic International, Inc, a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States and internationally. It utilizes C1-cell protein production platform based on an industrially proven microorganism (C1) for the development and production of biologic products including enzymes and other proteins for human and animal health.